NEW YORK (AP) — Omnicare Inc. said Tuesday it is giving up on its hostile bid to acquired fellow long-term pharmacy operator PharMerica Corp. after antitrust regulators opposed the deal.

Omnicare, of Covington, Ky., said Tuesday that it had allowed its tender offer for PharMerica shares to expire Friday. It did not buy any stock in PharMerica and all shares tendered will be returned.

PharMerica had always opposed the deal, which valued it at $457 million, or $15 per share.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.